SII manufactured BCG vaccine gets export nod to treat bladder cancer

The Serum Institute of India has been granted permission to export its BCG vaccine to Canada for the treatment of bladder cancer, following a request from the director, Prakash Kumar Singh. BCG as immunotherapy is a live freeze-dried preparation derived from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin) and is sold in 40mg and 80mg presentations.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news